Monday, November 2, 2026

New USFK Commander Takes Over as North Korea’s Actions Raise Concerns

General Xavier T. Brunson takes command of US Forces Korea amid concerns over North Korea's potential provocations.

Trump’s Orders: How the Ulchi Freedom Shield Exercises Were Cut Short

The Ulchi Freedom Shield exercise has been significantly reduced in duration and scale, following directives from President Donald Trump.

Coupang Faces Record Fine: What This Means for U.S. Tech Companies in Korea

The U.S. government is concerned over South Korea's fine on Coupang, highlighting regulatory issues affecting American tech firms.

Health

Curocell’s RIMQARTO: The Secret Behind Its Expanded Second-Line Treatment Indication

Curecell expands indications for the first domestic CAR-T therapy RIMQARTO, aiming to increase patient access with earlier treatment.

Leading Fertility Experts to Gather in Busan as Patients Seek Answers on Treatment Options

International reproductive immunology experts will gather in Busan to discuss the causes and treatment of infertility, with three public forums giving patients and families an opportunity to ask specialists directly about repeated IVF failures, recurrent miscarriages and possible treatment approaches.

Daewoong Pharmaceutical Targets Global Market With Long-Acting Injection and Patch Technologies

Daewoong Pharmaceutical is pursuing global opportunities with three next-generation drug delivery platforms designed for long-acting injections, microneedle patches and highly concentrated biologic formulations.

PRBom and MSD Korea Place Third in Global PR Awards for HPV Prevention Campaign

A decade-long campaign by PRBom and MSD Korea to raise awareness of HPV prevention has placed third in the 2026 Global SABRE Awards, standing out as the only South Korean campaign among the 40 finalists.

Celltrion Pharm Launches Prefilled-Syringe Version of Yuflyma in South Korea, Strengthening Price Competitiveness

Celltrion Pharm has launched a safety-equipped prefilled-syringe version of its Humira biosimilar Yuflyma in South Korea, expanding treatment options while offering one of the lowest prices among products containing the same active ingredient.
Latest

AACR 2026: How Korean Biotech Firms Are Leading the Charge in Cancer Research

AACR 2026 in San Diego will showcase South Korea's cancer tech innovations, featuring firms like Hanmi and Samsung Biologics.

Unlocking Future Healthcare: Insights from the 2026 Data Economy Conference

Sogang University hosts the 7th Data Economy Conference to discuss healthcare data commercialization and AI's role in biohealth.

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

Unlocking the Future of Health: How Myokines Could Revolutionize Diabetes Management in 2026

HLB Life Care signs MOU to research myokines, aiming for innovations in health and functional foods with a focus on diabetes and aging.

Experts Warn Untreated Gum Disease Linked to Bad Breath and Tooth Damage

Persistent bad breath may indicate gum disease, requiring treatment like scaling and proper hygiene for improvement.

Revolutionary Immune Therapy for Colon Cancer: How MAFB Protein Manipulation Enhances Treatment Response

Korea University researchers have developed a new colorectal cancer treatment strategy by regulating tumor-associated macrophages to enhance immune response.

Allergic Rhinitis Often Mistaken for Common Cold, Risk of Becoming Chronic if Untreated

Allergic rhinitis cases are rising with warmer weather; symptoms include sneezing and congestion. Treatment involves avoidance and medication.

2026’s Game-Changer: Canine Influenza Vaccine “CaniFlu-max” Now Approved for Subcutaneous Injection

A new subcutaneous influenza vaccine for dogs, CaniFlu-max, enhances treatment flexibility and has a strong safety profile.

5cc Syringe Shortage: What This Means for Parents of Critical Care Kids

A shortage of syringes due to Middle East crises is impacting caregivers, with prices skyrocketing and supplies nearly impossible to find.

44 Billion Won Drug Smuggling Case: How a Telegram Network Operated Illegal Pharmaceutical Sales

A South Korean drug gang has been indicted for selling $33 million in illegal pharmaceuticals, using messaging apps for distribution.

How ‘Sunlenkaju’ and ‘Sunlenkajeong’ Are Revolutionizing HIV-1 Therapy in 2026

FDA approves lenacapavir-based HIV treatments for patients with multidrug-resistant infections, enhancing options for difficult cases.

22,700 Deaths Highlight a Growing Antibiotic Resistance Crisis

Antibiotic resistance poses a severe threat, especially in nursing homes. Awareness and reduced usage are crucial to combat this growing crisis.

Samsung Bioepis Launches AI Academy: How 1,000 Employees Will Master AI by July 2026

Samsung Bioepis launches an AI training program for employees to enhance skills in biopharmaceuticals, boosting global competitiveness.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.